Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

Miles C. Andrews(The University of Texas MD Anderson Cancer Center), Connie P.M. Duong(Inserm), Vancheswaran Gopalakrishnan(The University of Texas MD Anderson Cancer Center), Valerio Iebba(Inserm), Wei-Shen Chen(The University of Texas MD Anderson Cancer Center), Lisa Derosa(Inserm), M.A. Wadud Khan(The University of Texas MD Anderson Cancer Center), Alexandria P. Cogdill(The University of Texas MD Anderson Cancer Center), Michael G. White(The University of Texas MD Anderson Cancer Center), Matthew C. Wong(The University of Texas MD Anderson Cancer Center), Gladys Ferrere(Inserm), Aurélie Fluckiger(Inserm), María Paula Roberti(Inserm), Paule Opolon(Institut Gustave Roussy), Maryam Tidjani Alou(Inserm), Satoru Yonekura(Inserm), Whijae Roh(The University of Texas MD Anderson Cancer Center), Christine N. Spencer(Parker Institute for Cancer Immunotherapy), Irina Fernandez Curbelo(The University of Texas MD Anderson Cancer Center), Luis M. Vence(The University of Texas MD Anderson Cancer Center), Alexandre Reuben(The University of Texas MD Anderson Cancer Center), Sarah B. Johnson(The University of Texas MD Anderson Cancer Center), Reetakshi Arora(The University of Texas MD Anderson Cancer Center), Golnaz Morad(The University of Texas MD Anderson Cancer Center), Matthew Lastrapes(The University of Texas MD Anderson Cancer Center), Erez N. Baruch(The University of Texas MD Anderson Cancer Center), Latasha Little(The University of Texas MD Anderson Cancer Center), Curtis Gumbs(The University of Texas MD Anderson Cancer Center), Zachary A. Cooper(AstraZeneca (United States)), Peter A. Prieto(University of Rochester Medical Center), Khalida Wani(The University of Texas MD Anderson Cancer Center), Alexander J. Lazar(The University of Texas MD Anderson Cancer Center), Michael T. Tetzlaff(The University of Texas MD Anderson Cancer Center), Courtney W. Hudgens(The University of Texas MD Anderson Cancer Center), Margaret K. Callahan(Memorial Sloan Kettering Cancer Center), Matthew Adamow(Memorial Sloan Kettering Cancer Center), Michael A. Postow(Memorial Sloan Kettering Cancer Center), Charlotte E. Ariyan(Memorial Sloan Kettering Cancer Center), Pierre-Olivier Gaudreau(The University of Texas MD Anderson Cancer Center), Luigi Nezi(European Institute of Oncology), Didier Raoult(Aix-Marseille Université), Catalin Mihalcioiu(McGill University Health Centre), Arielle Elkrief(McGill University Health Centre), Rossanna C. Pezo(Sunnybrook Health Science Centre), Lauren E. Haydu(The University of Texas MD Anderson Cancer Center), Julie M. Simon(The University of Texas MD Anderson Cancer Center), Hussein A. Tawbi(The University of Texas MD Anderson Cancer Center), Jennifer L. McQuade(The University of Texas MD Anderson Cancer Center), Patrick Hwu(The University of Texas MD Anderson Cancer Center), Wen-Jen Hwu(The University of Texas MD Anderson Cancer Center), Rodabe N. Amaria(The University of Texas MD Anderson Cancer Center), Elizabeth M. Burton(The University of Texas MD Anderson Cancer Center), Scott E. Woodman(The University of Texas MD Anderson Cancer Center), Stephanie S. Watowich(The University of Texas MD Anderson Cancer Center), Adi Diab(The University of Texas MD Anderson Cancer Center), Sapna P. Patel(The University of Texas MD Anderson Cancer Center), Isabella C. Glitza(The University of Texas MD Anderson Cancer Center), Michael K.K. Wong(The University of Texas MD Anderson Cancer Center), Li Zhao(The University of Texas MD Anderson Cancer Center), Jianhua Zhang(The University of Texas MD Anderson Cancer Center), Nadim J. Ajami(The University of Texas MD Anderson Cancer Center), Joseph F. Petrosino(Baylor College of Medicine), Robert R. Jenq(The University of Texas MD Anderson Cancer Center), Michael A. Davies(The University of Texas MD Anderson Cancer Center), Jeffrey E. Gershenwald(The University of Texas MD Anderson Cancer Center), P. Andrew Futreal(The University of Texas MD Anderson Cancer Center), Padmanee Sharma(The University of Texas MD Anderson Cancer Center), James P. Allison(The University of Texas MD Anderson Cancer Center), Bertrand Routy(Inserm), Laurence Zitvogel(Inserm), Jennifer A. Wargo(The University of Texas MD Anderson Cancer Center)
Nature Medicine
July 8, 2021
Cited by 410Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis